Analysis of prognosis in non-small cell lung cancer patients with platinum-based chemotherapy and bone marrow suppression

被引：0
作者：
Han, B. [1 ]
机构：
[1] Shanghai Chest Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e17532
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17532
引用
收藏
页数：1
相关论文
共 50 条
[31]   Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Patients [J].
Yin, Ji-Ye ;
Huang, Qiong ;
Zhao, Ying-Chun ;
Zhou, Hong-Hao ;
Liu, Zhao-Qian .
PLOS ONE, 2012, 7 (06)
[32]   Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems [J].
Xiong, Yi ;
Huang, Bi-Yun ;
Yin, Ji-Ye .
MEDICAL ONCOLOGY, 2017, 34 (04)
[33]   Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy [J].
Sullivan, Ivana ;
Salazar, Juliana ;
Majem, Margarita ;
Pallares, Cinta ;
del Rio, Elisabeth ;
Paez, David ;
Baiget, Montserrat ;
Barnadas, Agusti .
CANCER LETTERS, 2014, 353 (02) :160-166
[34]   Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems [J].
Yi Xiong ;
Bi-Yun Huang ;
Ji-Ye Yin .
Medical Oncology, 2017, 34
[35]   Randomized trial of feiyanning decoction in combination with platinum-based chemotherapy in advanced non-small cell lung cancer patients [J].
Xu, Z. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03) :S493-S493
[36]   Effect of Polymorphisms in XPD on Clinical Outcomes of Platinum-Based Chemotherapy for Chinese Non-Small Cell Lung Cancer Patients [J].
Wu, Wenting ;
Li, Huan ;
Wang, Huibo ;
Zhao, Xueying ;
Gao, Zhiqiang ;
Qiao, Rong ;
Zhang, Wei ;
Qian, Ji ;
Wang, Jiucun ;
Chen, Hongyan ;
Wei, Qingyi ;
Han, Baohui ;
Lu, Daru .
PLOS ONE, 2012, 7 (03)
[37]   INTRINSIC AND ACQUIRED RESISTANCE PATTERNS IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH PLATINUM-BASED CHEMOTHERAPY [J].
Stewart, David J. ;
Saintigny, Pierre ;
Lu, Charles ;
Goss, Glenwood .
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 :S862-S863
[38]   Haplotypes of BRCA1 and survival of non-small cell lung cancer patients treated with platinum-based chemotherapy [J].
Ryu, J. ;
Shin, E. ;
Lee, J. ;
Yoo, Y. ;
Cho, J. ;
Kim, H. ;
Lee, E. ;
Kim, C. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[39]   Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients [J].
Zhang, Shiheng ;
He, Le ;
Dai, Nan ;
Guan, Wei ;
Shan, Jinlu ;
Yang, Xueqin ;
Zhong, Zhaoyang ;
Qing, Yi ;
Jin, Feng ;
Chen, Chuan ;
Yang, Yuxin ;
Wang, Hongyi ;
Baugh, Laura ;
Tell, Gianluca ;
Wilson, David M., III ;
Li, Mengxia ;
Wang, Dong .
ONCOTARGET, 2016, 7 (47) :77482-77494
[40]   Association of POLK Polymorphisms with Platinum-Based Chemotherapy Response and Severe Toxicity in Non-small Cell Lung Cancer Patients [J].
Minhua Shao ;
Bo Jin ;
Yanjie Niu ;
Junyi Ye ;
Daru Lu ;
Baohui Han .
Cell Biochemistry and Biophysics, 2014, 70 :1227-1237
12345